Searchable abstracts of presentations at key conferences in endocrinology

ea0021p233 | Growth and development | SFEBES2009

A novel dominant-negative Glial Cells Missing B (GCMB) mutation (Asn502His) is associated with autosomal dominant hypoparathyroidism and results in reduced transactivation activity

Bowl Michael , Mirzcuk Samantha , Fratter Carl , Cranston Treena , Allgrove Jeremy , Brain Caroline , Nesbit Andrew , Thakker Rajesh

Glial cells missing B (GCMB), which is the mammalian homologue of the Drosophila GCM gene, encodes a 506 amino acid parathyroid-specific transcription factor that contains: a DNA-binding domain (residues 21–174); a predicted nuclear localization signal (residues 176–193); an inhibitory domain (residues 258–347); and two transactivation domains (residues 174–263, and residues 428–506). To date only two different GCMB m...

ea0049ep1092 | Developmental endocrinology | ECE2017

Age and developmental stage dependent relationship between plasma concentrations of leptin, luteinizing hormone, follicle stimulating hormone, prolactin, testosterone and inhibin B in boys between the age of 1 and 20 years

Naseem Afzaal Ahmed , Qayyum Mazhar , Akram Maleeha , Iqbal Zubaria , Tahir Fahim , Afshan Kiran , Jahan Sarwat , Rizvi Syed Shakeel Raza

Leptin is regarded as an essential adipokine for controlling energy homeostasis, caloric intake reduction and increase of caloric expenditure by negative feedback mechanisms via receptors in the hypothalamus. Puberty is said to be triggered by leptin, which signals the hypothalamus that adequate fat reserves are available for initiation of energetically costly process of reproduction. Leptin activates gonadotropin releasing hormone (GnRH) system, which stimulates luteinizing h...

ea0070aep854 | Reproductive and Developmental Endocrinology | ECE2020

Age and developmental stage dependent relationship between thyroid hormones and follicle stimulating hormone, luteinizing hormone, testosterone and inhibin B in boys between the ages of 1 and 20 years

Shakeel Raza Rizvi Syed , Ahmed Naseem Afzaal , Akram Maleeha , Tahir Fahim , Afshan Kiran , Jahan Sarwat , Qayyum Mazhar

The maturation of hypothalamo-pituitary-gonadal (HPG) axis causes the onset of puberty, which stimulates the development of secondary sex characteristics and changes in the size and composition of the body. Furthermore, the size of the thyroid gland increases and its function also changes as an adaptation to the requirements of the transformation of child to an adult. It has also been reported that the thyroid hormones including thyroxin (T4) and triiodothyronine (T3) have a f...

ea0029p1594 | Thyroid (non-cancer) | ICEECE2012

Enhanced expression of the B cell activation factor (BAFF) and baff-receptor (BAFF-R) in the thyroid and in the orbital adipose tissue from patients with graves’ disease (GD) and associated orbitopathy (GO)

Campi I. , Vannucchi G. , Covelli D. , Rossi S. , Doi P. , Curro N. , Pignataro L. , Guastella C. , Beck-Peccoz P. , Salvi M.

BAFF, a member of the TNF family, promotes autoantibody production by increasing B cell survival and proliferation. We have previously shown that serum BAFF concentrations are increased in GD patients. In the present work, we studied the expression of BAFF and BAFF-R, by immunohistochemistry (IHC) on paraffin embedded sections of: 1. orbital adipose tissue from 22 patients (5 men, 17 women) with GO (3 of them with active GO) associated with GD or Hashimoto thyroiditis in 19 an...

ea0011s29 | Novel peptides in reproduction | ECE2006

Novel recombinant gonadotropin molecules in human reproductive dysfunction

Mannaerts B , de Haan T , de Greef R

Org 36286 is a sustained follicular stimulant (SFS) inducing multiple follicular development in patients undergoing controlled ovarian stimulation. Due to its long half-life a single dose of Org 36286 may replace the first 7 injections of daily recFSH and after this one week interval, stimulation may be continued with daily recFSH up to the day of triggering ovulation (Org 36286 regimen). Ideally, recFSH should be started as soon as Org 36286 levels become too low to support m...

ea0013p61 | Clinical practice/governance and case reports | SFEBES2007

A 57 year old lady bilateral adrenal mass and adrenal insufficiency

Akhtar S , Dunne P , Mishra B

We report a case of a 57 year old lady who presented with marked weight loss, dizziness and general malaise. The physical examination revealed pallor, hypotension, tachycardia and dehydration. There was no muco-cutaneous pigmentation. Routine biochemistry showed normocytic anaemia, hyponatraemia, mild hyperkalaemia and renal impairment. Abdominal ultrasound showed presence of bilateral large supra-renal masses. A short synacthen test showed sub-optimal rise in plasma cortisol ...

ea0019p162 | Diabetes, Metabolism and Cardiovascular | SFEBES2009

Diabetic nephropathy: intense intervention or conventional care?

O'Leary H , Jose B , Lazarewicz K , De P

Introduction: All stages of diabetic nephropathy are independent risk factors for cardiovascular disease in patients with diabetes. Intensive intervention to achieve target glycaemic control, blood pressure and cholesterol can minimise cardiovascular risk, mainly by reducing proteinuria.Aims: To compare two cohorts of patients, group A, attending a nurse-led clinic in addition to the traditional diabetes renal clinic and group B attending the latter only...

ea0011p728 | Steroids | ECE2006

Capillary blood, an alternative to saliva for the diagnosis of Cushing’s syndrome?

Belaidi N , Mimouni S , Ourioux C , Gatta B , Corcuff JB

Introduction: As an alternative to cortisol assays in the serum or saliva to diagnose hypercorticisme we evaluated the ability of a commercial cortisol assay to assess capillary blood cortisol concentrations using routine procedures.Methods: Capillary blood was obtained using a device used by diabetics to routinely assess capillary glucose levels and deposited on Schleicher-Scheull 903 blotter paper (routinely used for neonatal diagnosis of hypothyroidis...

ea0038oc1.1 | Early Career Oral Communications | SFEBES2015

A novel pharmacological approach to target LH and testosterone hypersecretion in women with polycystic ovary syndrome: a randomised, double-blind, placebo-controlled multi-centre randomised clinical trial of the neurokinin B receptor antagonist AZD4901

George Jyothis , Kakkar Rahul , Marshall Jayne , Scott Martin , Finkelman Richard , Ho Tony , McIntosh Stuart , Veldhuis Johannes , Skorupskaite Karolina , Anderson Richard , Webber Lorraine

LH hyper-secretion, driven by increased GnRH pulsatility, underpins excess testosterone secretion – a key clinical feature of PCOS.The kisspeptin-neurokinin B (NKB)-GnRH pathway has emerged as the pivotal regulator of reproduction. We hypothesised that pharmacologic blockade of NKB may address the central pathophysiology of LH hyper-secretion and hyperandrogenism in PCOS. We undertook a randomised, double blind, placebo-controlled multi-centre Phase...

ea0019p315 | Steroids | SFEBES2009

Orexin-stimulated MAP Kinase cascades are activated through multiple G-protein signalling pathways in human H295R adrenocortical cells: differential regulation by orexin A and orexin B

Chen Jing , Ramanjaneya Manjunath , Conner Alex , Kumar Prashanth , Brown James , Johren Olaf , Lehnert Hendrik , Stanfield Peter , Randeva Harpal

Orexin-A and orexin-B orchestrate their diverse central and peripheral effects via two G-protein coupled receptors, OX1R and OX2R, which activate multiple G-proteins. They are involved in a host of physiological processes including, steroidogenesis, appetite control and energy regulation. Whilst some signalling mechanisms have been proposed for individual recombinant orexin receptors in generic mammalian cell types, it is clear that the peripheral effects of orexin are spatial...